SEC Insider Narrative: Menderes Akdag Sold $139,597 Worth of Petmed Express Inc (NASDAQ:PETS) Shares

November 29, 2016 - By Dolores Ford

SEC Insider Narrative: Menderes Akdag Sold $139,597 Worth of Petmed Express Inc (NASDAQ:PETS) Shares

Menderes Akdag Insider Sell

A legal document filed with the Washington-based SEC on November 29, 2016 revealed that Menderes Akdag, the CEO & President of Petmed Express Inc, ‘s company sold 6,274 shares. With average market share price of $22.3 the sale’s value is $139,597 U.S Dollars. In the last 30 days, he also sold 43,726 shares that are worth about $947,904 USD. Menderes Akdag right now owns 2.68% of the stock market capitalization of Petmed Express Inc.

Petmed Express Inc (NASDAQ:PETS) Ratings Coverage

Out of 2 analysts covering Petmed Express Inc (NASDAQ:PETS), 0 rate it a “Buy”, 1 “Sell”, while 1 “Hold”. This means 0 are positive. Petmed Express Inc has been the topic of 2 analyst reports since February 4, 2016 according to StockzIntelligence Inc. The rating was upgraded by Craig Hallum on Monday, May 9 to “Hold”. On Thursday, February 4 the stock rating was initiated by Credit Suisse with “Underperform”.

Insitutional Activity: The institutional sentiment increased to 1.03 in Q2 2016. Its up 0.15, from 0.88 in 2016Q1. The ratio is positive, as 17 funds sold all Petmed Express Inc shares owned while 51 reduced positions. 19 funds bought stakes while 41 increased positions. They now own 14.80 million shares or 6.13% less from 15.76 million shares in 2016Q1.

Amer Century Incorporated reported 68,253 shares or 0% of all its holdings. Moreover, Dekabank Deutsche Girozentrale has 0% invested in Petmed Express Inc (NASDAQ:PETS) for 2,353 shares. Panagora Asset Mngmt last reported 0% of its portfolio in the stock. Legal & General Group Inc Public Ltd has 3,837 shares for 0% of their US portfolio. Great West Life Assurance Can reported 5,800 shares or 0% of all its holdings. State Of Tennessee Treasury Department holds 0% or 16,181 shares in its portfolio. Creative Planning holds 0% of its portfolio in Petmed Express Inc (NASDAQ:PETS) for 2,913 shares. Fincl Bank Of Montreal Can has 0% invested in the company for 7,647 shares. Commercial Bank Of America Corp De holds 38,697 shares or 0% of its portfolio. Philadelphia Trust Company has 76,024 shares for 0.12% of their US portfolio. Shinko Asset holds 0.02% or 148,049 shares in its portfolio. Park Circle accumulated 30,000 shares or 0.41% of the stock. Clark Estates New York last reported 167,000 shares in the company. Millennium Ltd Liability Com holds 32,928 shares or 0% of its portfolio. Ls Inv Limited Liability Corporation last reported 686 shares in the company.

Insider Transactions: Since August 8, 2016, the stock had 0 insider buys, and 10 insider sales for $2.00 million net activity. The insider ROSENBLOOM BRUCE S sold $31,500. The insider AKDAG MENDERES sold $82,904. On Wednesday, August 10 the insider SCHWEITZER ROBERT C sold $61,755. FORMICA FRANK J also sold $217,500 worth of Petmed Express Inc (NASDAQ:PETS) shares.

About 50,634 shares traded hands. Petmed Express Inc (NASDAQ:PETS) has risen 19.04% since April 26, 2016 and is uptrending. It has outperformed by 13.78% the S&P500.

PetMed Express, Inc. , doing business as 1800PetMeds, is a pet pharmacy. The company has a market cap of $446.09 million. The Firm markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It has a 20.66 P/E ratio. It offers a selection of products for dogs and cats.

According to Zacks Investment Research, “Petmed Express is America’s largest pet pharmacy, delivering prescription and non-prescription pet medications and health and nutritional supplements for dogs and cats at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet.”

Analysts await Petmed Express Inc (NASDAQ:PETS) to report earnings on January, 23. They expect $0.24 EPS, 0.00% or $0.00 from last year’s $0.24 per share. PETS’s profit will be $4.83 million for 23.09 P/E if the $0.24 EPS becomes a reality. After $0.24 actual EPS reported by Petmed Express Inc for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

More recent Petmed Express Inc (NASDAQ:PETS) news were published by: Quotes.Wsj.com which released: “News PetMed Express Inc.PETS” on February 12, 2011. Also Nasdaq.com published the news titled: “Earnings Reaction History: PetMed Express, Inc., 25.0% Follow-Through ..” on October 24, 2016. Equitiesfocus.com‘s news article titled: “PetMed Express, Inc. (NASDAQ:PETS) 50-day Moving Average At $20.66” with publication date: November 29, 2016 was also an interesting one.

PETS Company Profile

PetMed Express, Inc. (PetMed Express), doing business as 1800PetMeds, incorporated on January 3, 1997, is a pet pharmacy. The Firm markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. The Firm offers a selection of products for dogs and cats. The Company’s product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Tags: , ,

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>